Abnormal regulation of cell membrane fluidity in diabetic nephropathy

Diabetologia

Volumn 41, Issue 3, 1998, Pages 337-342

  Jones, S C ^a,b   Thomas, T H ^a   Marshall, S M ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Anisotropy; Diabetic nephropathy; Erythrocyte; Fluidity; Insulin dependent diabetes mellitus; N ethylmaleimide

Indexed keywords

1,6 DIPHENYL 1,3,5 HEXATRIENE; N ETHYLMALEIMIDE;

ANISOTROPY; ARTICLE; CELL MEMBRANE FLUIDITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSKELETON; DIABETIC NEUROPATHY; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; LIPID BILAYER; PRIORITY JOURNAL;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CASE-CONTROL STUDIES; CREATININE; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DIPHENYLHEXATRIENE; ERYTHROCYTE MEMBRANE; ETHYLMALEIMIDE; FEMALE; FLUORESCENCE POLARIZATION; FLUORESCENT DYES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MEMBRANE FLUIDITY; MIDDLE AGED; SULFHYDRYL REAGENTS; TRIGLYCERIDES;

EID: 0031749808     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050912     Document Type: Article

References (23)

1. The Diabetes Control and Complications (DCCT) Research Group (1995) Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney Int 47: 1703-1720
2. Quinn M, Angelico MC, Warram JH, Krolewski AS (1996) Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 39: 940-945
3. Wiseman M, Viberti GC, MacIntosh D, Jarrett RJ, Keen H (1981) Glycaemia, arterial pressure and microalbuminuria in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 26: 401-405
4. Kofoed-Enevoldsen A, Jensen T, Borch-Johnsen K, Deckert T (1987) Incidence of diabetic retinopathy in type 1 (insulin dependent) diabetes: Association with clinical nephropathy. J Diabetic Complications 3: 96-99
5. Yip J, Mattock MB, Morocutti A, Sethi M, Trevisan R, Viberti GC (1993) Insulin resistance in insulin-dependent diabetic patients with microalbuminuria. Lancet 342: 883-887
6. Jensen T, Stender S, Deckert T (1988) Abnormalities in plasma concentrations of lipoproteins and fibrinogen in type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion. Diabetologia 31: 142-145
7. + antiport activity of cultured skin fibroblasts from diabetics. Kidney Int 42: 1184-1190
8. + antiport activity and cell growth in cultured skin fibroblasts of IDDM patients with nephropathy. Diabetes 41: 1239-1246
9. Mangili R, Bending JJ, Scott G, Li LK, Gupta A, Viberti GC (1988) Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy. N Engl J Med 318: 146-150
10. Jones SL, Trevisan R, Tariq T et al (1990) Sodium-lithium countertransport activity is increased in microalbuminuric diabetics. Hypertension 19: 570-575
11. Rutherford PA, Thomas TH, Carr SJ, Taylor R, Wilkinson R (1992) Changes in erythrocyte sodium-lithium counter-transport kinetics in diabetic nephropathy. Clin Sci 82: 301-307
12. Hasstedt SJ, Wu LL, Ash KO, Kuida H, Williams R (1988) Hypertension and sodium-lithium countertransport in Utah pedigrees: evidence for major locus inheritance. Am J Hum Genet 43: 14-22
13. Rutherford PA, Thomas TH, Wilkinson R (1992) Erythrocyte sodium-lithium countertransport: clinically useful, pathophysiologically instructive or just phenomenology? Clin Sci 82: 341-352
14. Donner M, Muller S, Stoltz JFG (1990) Fluorescence depolarisation method in the study of dynamic properties of blood cells. Biorheology 27:367-374
15. Schachter D, Cogan U, Abbott RE (1982) Asymmetry of lipid dynamics in human erythrocyte membranes studied with permanent fluorophores. Biochemistry 21: 2146-2150
16. Dowd A, Thomas TH, Taylor R, Wilkinson R (1994) Erythrocyte sodium-lithium countertransport is related to membrane fluidity in IDDM patients. Diabetologia 37: 394-400
17. Tong P, Thomas TH, Wilkinson R (1994) Membrane fluidity is different in intact erythrocytes and ghost membranes. Biochem Med Metab Biol 52: 132-135
18. Bennett V (1978) Purification of an active proteolytic fragment of the membrane attachment site for human erythrocyte spectrin. J Biol Chem 253: 2292-2299
19. Bennett V (1985) The membrane skeleton of human erythrocytes and its implications for more complex cells. Ann Rev Biochem 54: 273-304
20. Thomas TH, Rutherford PA, West IC, Wilkinson R (1995) Sulphydryl group control of sodium-lithium countertransport kinetics: a membrane protein control abnormality in essential hypertension. Eur J Clin Invest 25: 235-240
21. Jones SC, Thomas TH, Marshall SM (1997) Thiol group modulation of sodium-lithium countertransport kinetics in diabetic nephropathy. Diabetologia 40: 1079-1084
22. Tong P, Thomas T, Berrish T et al. (1995) Cell membrane dynamics and insulin resistance in non-insulin dependent diabetes mellitus. Lancet 345: 357-358
23. Vareesangthip K, Thomas TH, Tong P, Wilkinson R (1996) Erythrocyte membrane fluidity in adult polycystic disease:difference between intact cells and ghost membranes. Eur J Clin Invest 26: 171-173